SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Residential Real Estate Crash Index -- Ignore unavailable to you. Want to Upgrade?


To: Skeeter Bug who wrote (273593)9/6/2010 1:05:43 PM
From: Pogeu MahoneRespond to of 306849
 
These world wide conspiratorial drug manufacturers better get their kill rates up.
Your in a zone alright..


gardasil deaths...

Even you have more fingers and toes then there have been deaths from gardisil.

Reports to VAERS Following HPV Vaccination
Since licensed in October 2009, VAERS has received 3 adverse event reports occurring in the U.S. following Cervarix.

As of May 31, 2010, approximately 29.5 million doses of Gardasil were distributed in the United States.

As of May 31, 2010, there were 16,140 VAERS reports of adverse events following Gardasil vaccination in the United States. Of these reports, 92% were reports of events considered to be non-serious, and 8% were reports of events considered serious.

Based on all of the information we have today, CDC recommends HPV vaccination for the prevention of most types of cervical cancer. As with all approved vaccines, CDC and FDA will continue to closely monitor the safety of both HPV vaccines. Any problems detected with this vaccine will be reported to health officials, healthcare providers, and the public, and needed action will be taken to ensure the public's health and safety.

Non-serious adverse event reports
VAERS defines non-serious adverse events as those other than hospitalization, death, permanent disability, and life threatening illness.

The vast majority (92%) of the adverse events reports following Gardasil vaccination have included fainting, pain, and swelling at the injection site (the arm), headache, nausea, and fever. Fainting is common after injections and vaccinations, especially in adolescents. Falls after fainting may sometimes cause serious injuries, such as head injuries, which can be prevented by closely observing the vaccinated person for 15 minutes after vaccination.

Serious adverse event reports
VAERS defines serious adverse events as adverse events that involve hospitalization, permanent disability, life-threatening illness, and death. As with all VAERS reports, serious events may or may not have been caused by the vaccine.

All serious reports (8%) for Gardasil have been carefully analyzed by medical experts. Experts have not found a common medical pattern to the reports of serious adverse events reported for Gardasil that would suggest that they were caused by the vaccine. The following is a summary of selected serious adverse event reports that were submitted to VAERS between June 8, 2006 and May 31, 2010.

Guillain-Barré Syndrome (GBS)

Guillain-Barré Syndrome (GBS) has been reported after vaccination with Gardasil. GBS is a rare disorder that causes muscle weakness. It occurs in 1-2 out of every 100,000 people in their teens. A number of infections can cause GBS. There has been no indication that Gardasil increases the rate of GBS in girls and women above the rate expected in the general population, whether or not they were vaccinated.

Blood Clots

There have been some reports of blood clots after receiving Gardasil. These clots have occurred in the heart, lungs, and legs. Most of these people had a risk of getting blood clots, such as taking oral contraceptives (the birth control pill), smoking, obesity, and other risk factors.

Deaths

As of May 31, 2010, there have been 53 U.S. reports of death among females who have received Gardasil. Twenty nine of these reports have been confirmed and 24 remain unconfirmed due to no identifiable patient information in the report such as a name and contact information to confirm the report. Confirmed reports are those that scientists have followed up on and have verified the claim. In the 29 reports confirmed, there was no unusual pattern or clustering to the deaths that would suggest that they were caused by the vaccine.

More information is available at:

cdc.gov [PDF - 2.37 MB]
Summary of HPV Adverse Event Reports Published in JAMA

Reports of adverse events after getting a vaccine can be submitted to VAERS by fax at 1-877-721-0366, online at secure.vaers.org, or by mail to Vaccine Adverse Event Reporting System, P.O. Box 1100, Rockville, MD 20849-1100.